Response to antiviral therapy predicts the development of glucose abnormalities in patients with chronic HCV genotype 4 infection

被引:0
|
作者
Chehadeh, W. [1 ]
Al-Nakib, W. [1 ]
机构
[1] Kuwait Univ, Fac Med, Dept Microbiol, Virol Unit, Kuwait, Kuwait
关键词
D O I
10.1016/S1386-6532(09)70153-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:S31 / S31
页数:1
相关论文
共 50 条
  • [21] CLINICAL-SIGNIFICANCE OF HCV GENOTYPE IN CHRONIC HCV INFECTION IN HEMOPHILIC PATIENTS
    TELFER, PT
    DEVEREUX, H
    SAVAGE, K
    SCOTT, F
    DHILLON, AP
    DUSHEIKO, G
    LEE, CA
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1012 - 1012
  • [22] HLA CLASS I ALLELES ASSOCIATED WITH HCV POLYMORPHISMS AND RESPONSE TO ANTIVIRAL THERAPY IN HCV GENOTYPE 1-INFECTED PATIENTS
    Lange, C. M.
    Dragan, A.
    Roomp, K.
    Nattermann, J.
    Michalk, M.
    Spengler, U.
    Weich, V.
    Berg, T.
    Lengauer, T.
    Zeuzem, S.
    Sarrazin, C.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S270 - S270
  • [23] HCV-SPECIFIC T CELL RESPONSE IN PATIENTS WITH CHRONIC HIV/HCV CO-INFECTION IS NOT DEPENDENT OF HCV GENOTYPE
    Rallon, N.
    Soriano, V.
    Garcia-Samaniego, J.
    Lopez, M.
    Romero, M.
    Labarga, P.
    Gonzalez-Lahoz, J.
    Restrepo, C.
    Lozano, S.
    Peris, A.
    Benito, J. M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S322 - S322
  • [24] Silibinin is a potent antiviral agent in patients with chronic HCV infection not responding to peginterferon/ribavirin therapy
    Scherzer, Thomas-Matthias
    Hofer, Harald
    Schoeniger-Hekele, Maximilian
    Steindl-Munda, Petra
    Ferenci, Peter
    GASTROENTEROLOGY, 2008, 134 (04) : A829 - A829
  • [25] The impact of antiviral therapy on the course of chronic HCV infection -: A systematic review
    Almasio, PL
    Venezia, G
    Craxì, A
    PANMINERVA MEDICA, 2003, 45 (03) : 175 - 182
  • [26] The impact of antiviral therapy on the course of chronic HCV infection: A systematic review
    Almasio, PL
    Venezia, G
    Craxi, A
    JOURNAL OF HEPATOLOGY, 2003, 38 : 123 - 123
  • [27] New antiviral therapy and the quality of life in patients with HCV infection
    Danilescu, Claudia Monica
    Rogoveanu, Ion
    Sandulescu, Daniela Larisa
    Gheorman, Victor
    Cara, Monica Laura
    Pirlog, Mihail Cristian
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E216 - E216
  • [28] A Polymorphism in the Microsomal Triglyceride Transfer Protein Can Predict the Response to Antiviral Therapy in Egyptian Patients with Chronic Hepatitis C Virus Genotype 4 Infection
    Saad, Yasmin
    Shaker, Olfat
    Nassar, Yasser
    Ahmad, Lama
    Said, Mohamed
    Esmat, Gamal
    GUT AND LIVER, 2014, 8 (06) : 655 - 661
  • [29] EXPERIENCE OF EFFECTIVE ANTIVIRAL THERAPY IN A LIVER RECIPIENT WITH RECURRENT HCV INFECTION GENOTYPE 1
    Umrik, D. V.
    Tsiroulnikova, O. M.
    Miloserdov, I. A.
    Latypov, R. A.
    Egorova, E. T.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2018, 20 (04): : 54 - 60
  • [30] HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
    Pellicelli, Adriano M.
    Romano, Mario
    Stroffolini, Tommaso
    Mazzoni, Ettore
    Mecenate, Fabrizio
    Monarca, Roberto
    Picardi, Antonio
    Bonaventura, Maria Elena
    Mastropietro, Cristina
    Vignally, Pascal
    Andreoli, Arnaldo
    Marignani, Massimo
    D'Ambrosio, Cecilia
    Miglioresi, Lucia
    Nosotti, Lorenzo
    Mitidieri, Olga
    Gentilucci, Umberto Vespasiani
    Puoti, Claudio
    Barbaro, Giuseppe
    Barlattani, Angelo
    Furlan, Caterina
    Barbarini, Giorgio
    BMC GASTROENTEROLOGY, 2012, 12